4-Methylmorpholine → Ethyl 2-(3-{[(4-chloro-5-ethyl-1H-imidazol-2-yl)carbonyl]amino}azetidin-1-yl)-1,3-thiazole-5-carboxylate
反応式
CCN=C=NCCCN(C)C.Cl.ON1C2C=CC=CC=2N=N1.CN1CCOCC1.[NH2:30][CH:31]1[CH2:34][N:33]([C:35]2[S:36][C:37]([C:40]([O:42][CH2:43][CH3:44])=[O:41])=[CH:38][N:39]=2)[CH2:32]1.[Cl:45][C:46]1[N:47]=[C:48]([C:53](O)=[O:54])[NH:49][C:50]=1[CH2:51][CH3:52]>CC(N(C)C)=O.ClCCl.C(OCC)(=O)C>[Cl:45][C:46]1[N:47]=[C:48]([C:53]([NH:30][CH:31]2[CH2:34][N:33]([C:35]3[S:36][C:37]([C:40]([O:42][CH2:43][CH3:44])=[O:41])=[CH:38][N:39]=3)[CH2:32]2)=[O:54])[NH:49][C:50]=1[CH2:51][CH3:52]参加物
反応物 5
生成物 1
試薬・触媒・溶媒 2
実験手順
WSC hydrochloride (62 mg, 0.32 mmol), 1-hydroxybenzotriazole (36 mg, 0.27 mmol) and N-methylmorpholine (0.06 mL, 0.54 mmol) were added to a mixed solution of ethyl 2-(3-aminoazetidin-1-yl)-1,3-thiazole-5-carboxylate obtained in Example (217b) (61 mg, 0.27 mmol) and 4-chloro-5-ethyl-1H-imidazole-2-carboxylic acid obtained in Example (1d) (47 mg, 0.27 mmol) in DMA/dichloromethane (2 mL/2 mL), and the mixture was stirred at room temperature for 19 hours. The reaction solution was diluted with ethyl acetate, and then the mixture was washed with brine and dried over anhydrous magnesium sulfate. Following filtration, the solvent was evaporated under reduced pressure. The resulting residue was purified by silica gel column chromatography (elution solvent: dichloromethane/methanol=20/1) to obtain 66 mg of the title compound as a white solid (64%).
後処理
- washthe mixture was washed with brine
- dry with materialdried over anhydrous magnesium sulfate
- filtrationfiltration
- customthe solvent was evaporated under reduced pressure
- customThe resulting residue was purified by silica gel column chromatography (elution solvent: dichloromethane/methanol=20/1)
出典と根拠
- ORDレコード
- ord-e31b73c0a8cf46a081abd3ea44213e4e
- 出典データセット
- uspto-grants-2013_09
- 特許番号
- US08536197B2
反応ノート
読み込み中…